Peer-influenced content. Sources you trust. No registration required. This is HCN.
Practical Neurology
“Fenebrutinib represents the first potential scientific breakthrough for the PPMS community in over a decade.” — Levi Garraway, MD, PhD, Roche Chief Medical Officer
Neurology February 19th 2026